Expanding Anatomic Infrastructure for Scaling Manufacturing Operations

Anatomic, a University of Minnesota start-up company based in Minnesota, develops neural tissues used in basic science and drug development. Its current flagship product, RealDRG, can be used to support development of novel non-opioid pain medications to address the ongoing, major unmet clinical need given the substantial life loss due to the opioid epidemic. This grant will support expansion of Anatomic's facilities to produce additional neural tissues that will enable researchers to understand central mechanisms of pain and amyotrophic lateral sclerosis (ALS) resulting in new therapies for these diseases.